Thiotepa–busulfan–fludarabine (TBF) conditioning regimen in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis: an outcome analysis from the Chronic Malignancies Working Party of the EBMT

  1. Battipaglia, G.
  2. Mauff, K.
  3. Wendel, L.
  4. Angelucci, E.
  5. Mohty, M.
  6. Arcese, W.
  7. Santarone, S.
  8. Rubio, M.T.
  9. Kroger, N.
  10. Fox, M.L.
  11. Blaise, D.
  12. Iori, A.P.
  13. Fanin, R.
  14. Chalandon, Y.
  15. Pioltelli, P.
  16. Marotta, G.
  17. Chiusolo, P.
  18. Sever, M.
  19. Solano, C.
  20. Contentin, N.
  21. de Wreede, L.C.
  22. Czerw, T.
  23. Hernandez-Boluda, J.C.
  24. Hayden, P.
  25. McLornan, D.
  26. Yakoub-Agha, I.
  27. Show all authors +
Journal:
Bone Marrow Transplantation

ISSN: 1476-5365 0268-3369

Year of publication: 2021

Volume: 56

Issue: 7

Pages: 1593-1602

Type: Article

DOI: 10.1038/S41409-021-01222-Z GOOGLE SCHOLAR